Targeted therapy as a new opportunity for lung cancer, breast cancer and prostate cancer. New medications and active ingredients against this type of tumor cell are highly effective and relatively well tolerated.
Study results presented at the European Cancer Congress ESMO also show that these targeted therapies are effective even in the early stages of the disease and drastically reduce the risk of relapse. Dr. med. Jan Stratmann, specialist in internal medicine and oncologist at the Johann Wolfgang Goethe University Hospital in Frankfurt am Main, explains the possibilities of targeted cancer therapy.